A detailed history of Northern Trust Corp transactions in Avid Bioservices, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 646,708 shares of CDMO stock, worth $7.72 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
646,708
Previous 666,444 2.96%
Holding current value
$7.72 Million
Previous $4.76 Million 54.67%
% of portfolio
0.0%
Previous 0.0%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$6.7 - $12.45 $132,231 - $245,713
-19,736 Reduced 2.96%
646,708 $7.36 Million
Q2 2024

Aug 14, 2024

SELL
$6.34 - $9.28 $131,485 - $192,457
-20,739 Reduced 3.02%
666,444 $4.76 Million
Q1 2024

May 14, 2024

SELL
$5.86 - $8.79 $20,468 - $30,703
-3,493 Reduced 0.51%
687,183 $4.6 Million
Q4 2023

Feb 13, 2024

SELL
$4.64 - $9.56 $8,468 - $17,447
-1,825 Reduced 0.26%
690,676 $4.49 Million
Q3 2023

Nov 13, 2023

BUY
$9.4 - $14.04 $16,553 - $24,724
1,761 Added 0.25%
692,501 $6.54 Million
Q2 2023

Aug 11, 2023

BUY
$12.96 - $20.93 $302,784 - $488,987
23,363 Added 3.5%
690,740 $9.65 Million
Q1 2023

May 15, 2023

SELL
$13.48 - $18.79 $60,471 - $84,291
-4,486 Reduced 0.67%
667,377 $12.5 Million
Q4 2022

Feb 13, 2023

BUY
$12.61 - $18.74 $177,964 - $264,477
14,113 Added 2.15%
671,863 $9.25 Million
Q3 2022

Nov 14, 2022

BUY
$15.33 - $20.36 $5,886 - $7,818
384 Added 0.06%
657,750 $12.6 Million
Q2 2022

Aug 12, 2022

SELL
$11.63 - $21.55 $81,351 - $150,742
-6,995 Reduced 1.05%
657,366 $10 Million
Q1 2022

May 13, 2022

SELL
$16.63 - $27.73 $1.7 Million - $2.84 Million
-102,435 Reduced 13.36%
664,361 $13.5 Million
Q4 2021

Feb 08, 2022

BUY
$20.7 - $34.18 $1.26 Million - $2.08 Million
60,928 Added 8.63%
766,796 $22.4 Million
Q3 2021

Nov 15, 2021

SELL
$19.05 - $28.32 $430,758 - $640,371
-22,612 Reduced 3.1%
705,868 $15.2 Million
Q2 2021

Aug 13, 2021

BUY
$18.93 - $25.65 $1.35 Million - $1.83 Million
71,241 Added 10.84%
728,480 $18.7 Million
Q1 2021

May 12, 2021

SELL
$11.86 - $21.77 $119,797 - $219,898
-10,101 Reduced 1.51%
657,239 $12 Million
Q4 2020

Feb 11, 2021

SELL
$7.25 - $11.76 $34,785 - $56,424
-4,798 Reduced 0.71%
667,340 $7.7 Million
Q3 2020

Nov 16, 2020

SELL
$6.53 - $8.6 $166,116 - $218,775
-25,439 Reduced 3.65%
672,138 $5.12 Million
Q2 2020

Aug 14, 2020

BUY
$4.11 - $6.78 $96,350 - $158,943
23,443 Added 3.48%
697,577 $4.58 Million
Q1 2020

May 14, 2020

BUY
$3.15 - $7.39 $79,959 - $187,587
25,384 Added 3.91%
674,134 $3.45 Million
Q4 2019

Feb 14, 2020

BUY
$5.01 - $8.16 $25,741 - $41,926
5,138 Added 0.8%
648,750 $4.98 Million
Q3 2019

Nov 13, 2019

BUY
$5.07 - $7.08 $231,359 - $323,081
45,633 Added 7.63%
643,612 $3.41 Million
Q2 2019

Aug 13, 2019

BUY
$3.43 - $5.6 $57,332 - $93,604
16,715 Added 2.88%
597,979 $3.35 Million
Q1 2019

May 13, 2019

SELL
$3.56 - $4.82 $70,128 - $94,949
-19,699 Reduced 3.28%
581,264 $2.47 Million
Q4 2018

Feb 12, 2019

SELL
$4.04 - $6.75 $75,576 - $126,272
-18,707 Reduced 3.02%
600,963 $2.46 Million
Q3 2018

Nov 14, 2018

BUY
$4.28 - $7.32 $217,355 - $371,738
50,784 Added 8.93%
619,670 $4.25 Million
Q2 2018

Aug 14, 2018

BUY
$3.1 - $3.93 $1.4 Million - $1.78 Million
451,916 Added 386.35%
568,886 $2.23 Million
Q1 2018

May 09, 2018

BUY
$2.32 - $4.22 $271,370 - $493,613
116,970 New
116,970 $342,000

Others Institutions Holding CDMO

About Avid Bioservices, Inc.


  • Ticker CDMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,167,500
  • Market Cap $742M
  • Description
  • Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...
More about CDMO
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.